Compare BridgeBio Pharma Inc (BBIO) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Inovio Pharmaceuticals Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $76.09M). The key difference: BridgeBio Pharma Inc is far larger — about 218.3× Inovio Pharmaceuticals Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | INO | |
|---|---|---|
Market Cap | $16.61B | $76.09M |
Sector | Health | Health |
52-Week High | $90.17 | $2.87 |
52-Week Low | $47.29 | $0.66 |
Enterprise Value | $18.16B | $47.10M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
